Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of A Combination Stem Cell Therapy is Safe and Feasible in the Development of Mature Stable Vessels in Ischemic Limbs

NCT00518401 is registered in ClinicalTrials.gov with TCA Cellular Therapy as lead sponsor.

NCT NCT00518401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00518401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of A Combination Stem Cell Therapy is Safe and Feasible in the Development of Mature Stable Vessels in Ischemic Limbs
Lead sponsor
TCA Cellular Therapy
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2009
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral vascular disease